{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:46:29Z","timestamp":1761129989539,"version":"3.37.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T00:00:00Z","timestamp":1648425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T00:00:00Z","timestamp":1648425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Advicenne SA"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Consequences of distal renal tubular acidosis (dRTA) on growth, bone and kidney, sometimes associated with hearing loss, may significantly affect quality of life (QoL). This descriptive qualitative study explores QoL linked to dRTA and gathers the impressions of patients with this rare disease (and caregivers) 5\u00a0years after enrolment in a clinical study, during which patients were treated with ADV7103, a prolonged-release granule formulation combining potassium citrate and potassium bicarbonate. Semi-structured, one-hour interviews with 6 adult and 13 paediatric patients with a confirmed diagnosis of dRTA and with parents of paediatric patients were performed using an interview guide. Qualitative analysis of anonymized interview transcripts based on grounded theory was conducted.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The main QoL domains impacted by dRTA and its treatment were education\/work, social\/family life, and emotional and physical well-being. ADV7103 (administered twice daily) was compared with the standard of care (SoC) taken before study entry (more than twice daily). Patients\/parents reported that switching from previous SoC to ADV7103 had changed their lives:<jats:list list-type=\"bullet\"><jats:list-item><jats:p>Difficulties at school due to burdensome administrative issues and need to explain disease and treatment affecting all families of paediatric patients (n\u2009=\u200913) disappeared, facilitating parents who had stopped working (to deal with their child\u2019s treatment) to return to work,<\/jats:p><\/jats:list-item><jats:list-item><jats:p>Family functioning was improved (n\u2009=\u200918), as travel and holidays became easier to organise and patients\/parents stopped thinking about managing treatment daily\/nightly, reducing tension in the family or couple,<\/jats:p><\/jats:list-item><jats:list-item><jats:p>The emotional burden of disease perceived was relieved (n\u2009=\u200912) in the absence of treatment-related invasive questions from others,<\/jats:p><\/jats:list-item><jats:list-item><jats:p>Gastro-intestinal adverse events and taste problems improved with ADV7103 (n\u2009=\u200918) and better compliance led to milder physical impacts and less need to be hospitalised.<\/jats:p><\/jats:list-item><\/jats:list><\/jats:p><jats:p>The mean satisfaction score with ADV7103 compared to SoC was 9 out of 10 (10\u2009=\u2009very satisfied). ADV7103 exceeded or met the expectations of 14 out of 17 patients that commented on that.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Qualitative interviews show that dRTA and its treatment have a significant impact on QoL of patients and parents and that ADV7103 helps improve daily-life and reduces treatment burden, resulting in greater overall satisfaction of the patients and their families.<\/jats:p><jats:p><jats:italic>Trial registration<\/jats:italic>EU Clinical Trials Register, EudraCT 2013-003828-36 on the 3rd of September 2013.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13023-022-02294-w","type":"journal-article","created":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T00:04:03Z","timestamp":1648512243000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Lived experiences of patients with distal renal tubular acidosis treated with ADV7103 and of their caregivers: a qualitative study"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9040-9149","authenticated-orcid":false,"given":"Micha\u00ebl","family":"Acquadro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexia","family":"Marrel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5056-9065","authenticated-orcid":false,"given":"Maria A.","family":"Manso-Silv\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Guittet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Joukoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4207-824X","authenticated-orcid":false,"given":"Aur\u00e9lia","family":"Bertholet-Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,28]]},"reference":[{"key":"2294_CR1","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1159\/000478781","volume":"3","author":"F Trepiccione","year":"2017","unstructured":"Trepiccione F, Prosperi F, de la Motte LR, H\u00fcbner CA, Chambrey R, Eladari D, et al. New findings on the pathogenesis of distal renal tubular acidosis. Kidney Dis. 2017;3:98\u2013105.","journal-title":"Kidney Dis"},{"key":"2294_CR2","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1053\/j.ackd.2018.05.003","volume":"25","author":"PG Vall\u00e9s","year":"2018","unstructured":"Vall\u00e9s PG, Batlle D. Hypokalemic distal renal tubular acidosis. Adv Chronic Kidney Dis. 2018;25:303\u201320.","journal-title":"Adv Chronic Kidney Dis"},{"key":"2294_CR3","unstructured":"Alexander RT, Law L, Gil-Pe\u00f1a H, Greenbaum LA, Santos FM. Hereditary Distal Renal Tubular Acidosis. In: Adam MP AH, Pagon RA, et al., editors. GeneReviews\u00ae [Internet]."},{"key":"2294_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.5049\/EBP.2017.15.1.17","volume":"15","author":"SW Jung","year":"2017","unstructured":"Jung SW, Park EJ, Kim JS, Lee TW, Ihm CG, Lee SH, et al. Renal tubular acidosis in patients with primary Sj\u00f6gren\u2019s syndrome. Electrolyte Blood Press. 2017;15:17\u201322.","journal-title":"Electrolyte Blood Press"},{"key":"2294_CR5","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3109\/s10165-012-0633-x","volume":"23","author":"R Bogdanovic","year":"2013","unstructured":"Bogdanovic R, Basta-Jovanovic G, Putnik J, Stajic N, Paripovic A. Renal involvement in primary Sjogren syndrome of childhood: case report and literature review. Mod Rheumatol. 2013;23:182\u20139.","journal-title":"Mod Rheumatol"},{"key":"2294_CR6","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.semnephrol.2006.12.001","volume":"26","author":"D Batlle","year":"2006","unstructured":"Batlle D, Moorthi KM, Schlueter W, Kurtzman N. Distal renal tubular acidosis and the potassium enigma. Sem Nephrol. 2006;26:471\u20138.","journal-title":"Sem Nephrol"},{"key":"2294_CR7","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s00467-016-3573-4","volume":"32","author":"MTP Besouw","year":"2017","unstructured":"Besouw MTP, Bienias M, Walsh P, Kleta R, Van\u2019t Hoff WG, Ashton E, et al. Clinical and molecular aspects of distal renal tubular acidosis in children. Pediatr Nephrol. 2017;32:987\u201396.","journal-title":"Pediatr Nephrol"},{"key":"2294_CR8","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.kint.2016.12.017","volume":"91","author":"V Palazzo","year":"2017","unstructured":"Palazzo V, Provenzano A, Becherucci F, Sansavini G, Mazzinghi B, Orlandini V, et al. The genetic and clinical spectrum of a large cohort of patients with distal renal tubular acidosis. Kidney Int. 2017;91:1243\u201355.","journal-title":"Kidney Int"},{"key":"2294_CR9","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1172\/JCI108962","volume":"61","author":"E McSherry","year":"1978","unstructured":"McSherry E, Morris RC Jr. Attainment and maintenance of normal stature with alkali therapy in infants and children with classic renal tubular acidosis. J Clin Invest. 1978;61:509\u201327.","journal-title":"J Clin Invest"},{"key":"2294_CR10","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1093\/ndt\/gfy409","volume":"34","author":"SC Lopez-Garcia","year":"2019","unstructured":"Lopez-Garcia SC, Emma F, Walsh SB, Fila M, Hooman N, Zaniew M, et al. Treatment and long-term outcome in primary distal renal tubular acidosis. Nephrol Dial Transplant. 2019;34:981\u201391.","journal-title":"Nephrol Dial Transplant"},{"key":"2294_CR11","doi-asserted-by":"publisher","first-page":"13960","DOI":"10.1038\/s41598-020-70549-2","volume":"10","author":"C Guittet","year":"2020","unstructured":"Guittet C, Roussel-Maupetit C, Manso-Silvan MA, Guillaumin F, Vandenhende F, Granier LA. Innovative prolonged-release oral alkalising formulation allowing sustained urine pH increase with twice daily administration: randomised trial in healthy adults. Sci Rep. 2020;10:13960.","journal-title":"Sci Rep"},{"key":"2294_CR12","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00467-020-04693-2","volume":"36","author":"A Bertholet-Thomas","year":"2021","unstructured":"Bertholet-Thomas A, Guittet C, Manso-Silvan MA, Castang A, Baudouin V, Cailliez M, et al. Efficacy and safety of an innovative prolonged-release combination drug in patients with distal renal tubular acidosis: an open-label comparative trial versus standard of care treatments. Pediatr Nephrol. 2021;36:83\u201391.","journal-title":"Pediatr Nephrol"},{"key":"2294_CR13","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1007\/s00467-020-04873-0","volume":"36","author":"A Bertholet-Thomas","year":"2021","unstructured":"Bertholet-Thomas A, Guittet C, Manso-Silv\u00e1n MA, Joukoff S, Navas-Serrano V, Baudouin V, et al. Safety, efficacy, and acceptability of ADV7103 during 24 months of treatment: an open-label study in pediatric and adult patients with distal renal tubular acidosis. Pediatr Nephrol. 2021;36:1765\u201374.","journal-title":"Pediatr Nephrol"},{"key":"2294_CR14","unstructured":"ICH. ICH reflection paper. Proposed ICH guideline work to advance patient focused drug development. 2020."},{"key":"2294_CR15","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.pec.2010.12.021","volume":"82","author":"N Britten","year":"2011","unstructured":"Britten N. Qualitative research on health communication: what can it contribute? Patient Educ Couns. 2011;82:384\u20138.","journal-title":"Patient Educ Couns"},{"key":"2294_CR16","doi-asserted-by":"publisher","first-page":"e002889","DOI":"10.1136\/bmjopen-2013-002889","volume":"3","author":"A O'Cathain","year":"2013","unstructured":"O\u2019Cathain A, Thomas KJ, Drabble SJ, Rudolph A, Hewison J. What can qualitative research do for randomised controlled trials? A systematic mapping review. BMJ Open. 2013;3:e002889.","journal-title":"BMJ Open"},{"key":"2294_CR17","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.jval.2020.11.007","volume":"24","author":"J Willis","year":"2021","unstructured":"Willis J, Zeratkaar D, ten Hove J, Rosenbaum P, Ronen GM. Engaging the voices of children: A scoping review of how children and adolescents are involved in the development of quality-of-life-related measures. Value in Health. 2021;24:556\u201367.","journal-title":"Value in Health"},{"key":"2294_CR18","volume-title":"The discovery of grounded theory: Strategies for qualitative research","author":"BG Glaser","year":"1967","unstructured":"Glaser BG, Strauss AL. The discovery of grounded theory: Strategies for qualitative research. New York: Aldine de Gruyter; 1967."},{"key":"2294_CR19","volume-title":"Qualitative data analysis: An expanded sourcebook","author":"M Miles","year":"1994","unstructured":"Miles M, Huberman A. Qualitative data analysis: An expanded sourcebook. Thousand Oaks: CA Sage Publications; 1994."},{"key":"2294_CR20","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77\u2013101.","journal-title":"Qual Res Psychol"},{"key":"2294_CR21","doi-asserted-by":"publisher","DOI":"10.4135\/9781473906907","volume-title":"Using software in qualitative research: A step-by-step guide","author":"C Silver","year":"2014","unstructured":"Silver C, Lewins A. Using software in qualitative research: A step-by-step guide. Thousand Oaks: Sage Publications; 2014."},{"key":"2294_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-15671-8","volume-title":"Analyzing qualitative data with MAXQDA Text, audio and video","author":"U Kuckartz","year":"2019","unstructured":"Kuckartz U, R\u00e4diker S. Analyzing qualitative data with MAXQDA Text, audio and video. Berlin: Springer; 2019."},{"key":"2294_CR23","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1177\/104973239500500201","volume":"5","author":"J Morse","year":"1995","unstructured":"Morse J. The significance of saturation. Qual Health Res. 1995;5:147\u20139.","journal-title":"Qual Health Res"},{"key":"2294_CR24","doi-asserted-by":"publisher","first-page":"e0181689","DOI":"10.1371\/journal.pone.0181689","volume":"12","author":"FJ van Rijnsoever","year":"2017","unstructured":"van Rijnsoever FJ. (I can\u2019t get no) saturation: A simulation and guidelines for sample sizes in qualitative research. PLoS ONE. 2017;12:e0181689.","journal-title":"PLoS ONE"},{"key":"2294_CR25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4135\/9781446221792","volume-title":"Rethinking methods in psychology","author":"JA Smith","year":"1995","unstructured":"Smith JA. Semi structured interviewing and qualitative analysis. In: Smith JA, Harre R, van Longehnhove L, editors. Rethinking methods in psychology. Thousand Oaks: Sage Publications; 1995. p. 9\u201326."},{"key":"2294_CR26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4135\/9781446221792.n3","volume-title":"Rethinking methods in psychology","author":"K Charmaz","year":"1995","unstructured":"Charmaz K. Grounded theory. In: Smith JA, Harre R, van Longehnhove L, editors. Rethinking methods in psychology. Thousand Oaks: Sage Publications; 1995. p. 27\u201349."},{"key":"2294_CR27","first-page":"e22","volume":"15","author":"SD Saini","year":"2009","unstructured":"Saini SD, Schoenfeld P, Kaulback K, Dubinsky MC. Effect of medication dosing frequency on adherence in chronic diseases. Am J Manag Care. 2009;15:e22-33.","journal-title":"Am J Manag Care"},{"key":"2294_CR28","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/S0149-2918(01)80109-0","volume":"23","author":"AJ Claxton","year":"2001","unstructured":"Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001;23:1296\u2013310.","journal-title":"Clin Ther"},{"key":"2294_CR29","first-page":"189","volume":"1","author":"LR Martin","year":"2005","unstructured":"Martin LR, Williams SL, Haskard KB, Dimatteo MR. The challenge of patient adherence. Ther Clin Risk Manag. 2005;1:189\u201399.","journal-title":"Ther Clin Risk Manag"},{"key":"2294_CR30","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1097\/00005650-200209000-00009","volume":"40","author":"MR DiMatteo","year":"2002","unstructured":"DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care. 2002;40:794\u2013811.","journal-title":"Med Care"},{"issue":"7557","key":"2294_CR31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/bmj.38875.675486.55","volume":"333","author":"SH Simpson","year":"2006","unstructured":"Simpson SH, Eurich DT, Majumdar SR, Padwal RS, Tsuyuki RT, Varney J, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;333(7557):15.","journal-title":"BMJ"},{"key":"2294_CR32","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.amjmed.2006.08.033","volume":"120","author":"S Bangalore","year":"2007","unstructured":"Bangalore S, Kamalakkannan G, Parkar S, Messerli FH. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med. 2007;120:713\u20139.","journal-title":"Am J Med"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02294-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-022-02294-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02294-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T15:20:02Z","timestamp":1675092002000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-022-02294-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,28]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2294"],"URL":"https:\/\/doi.org\/10.1186\/s13023-022-02294-w","relation":{},"ISSN":["1750-1172"],"issn-type":[{"type":"electronic","value":"1750-1172"}],"subject":[],"published":{"date-parts":[[2022,3,28]]},"assertion":[{"value":"5 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Patients and caregivers provided written informed consent prior to being interviewed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Patients and caregivers provided consent for the use of anonymized quotes in publications.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"A. Bertholet-Thomas has received support from Advicenne for traveling to meetings and\/or funding for lectures. M.A. Manso-Silv\u00e1n and C. Guittet are employees of Advicenne and hold stock options\/shares in the company. Sophie Joukoff is also an employee of Advicenne. A. Marrel and M. Acquadro, employees of ICON plc at the time the study was conducted, were under contract research with Advicenne.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"141"}}